Towards a Better Understanding of Verapamil Release from Kollicoat SR:IR Coated Pellets Using Non-Invasive Analytical Tools

Abstract

The aim of this study was to gain deeper insight into the mass transport mechanisms controlling drug release from polymer-coated pellets using non-invasive analytical tools. Pellet starter cores loaded with verapamil HCl (10% loading, 45% lactose, 45% microcrystalline cellulose) were prepared by extrusion/spheronization and coated with 5% Kollicoat SR:IR 95:5 or 10% Kollicoat SR:IR 90:10. Drug release was measured from ensembles of pellets as well as from single pellets upon exposure to acetate buffer pH = 3.5 and phosphate buffer pH = 7.4. The swelling of single pellets was observed by optical microscopy, while dynamic changes in the pH in the pellet cores were monitored by fluorescence spectroscopy. Also, mathematical modeling using a mechanistically realistic theory as well as SEM and Raman imaging were applied to elucidate whether drug release mainly occurs by diffusion through the intact film coatings or whether crack formation in the film coatings plays a role. Interestingly, fluorescence spectroscopy revealed that the pH within the pellet cores substantially differed upon exposure to acetate buffer pH = 3.5 and phosphate buffer pH = 7.4, resulting in significant differences in drug solubility (verapamil being a weak base) and faster drug release at lower pH: from ensembles of pellets and single pellets. The monitoring of drug release from and the swelling of single pellets indicated that crack formation in the film coatings likely plays a major role, irrespective of the Kollicoat SR:IR ratio/coating level. This was confirmed by mathematical modeling, SEM and Raman imaging. Importantly, the latter technique allowed also for non-invasive measurements, reducing the risk of artifact creation associated with sample cutting with a scalpel.

Design and Optimization of a Nanoparticulate Pore Former as a Multifunctional Coating Excipient for pH Transition-Independent Controlled Release of Weakly Basic Drugs for Oral Drug Delivery

“…In contrast, conventional formulations may rely on a combination of pH m modifiers (e.g., fumaric acid) and enteric coating polymers (e.g., hydroxypropyl methylcellulose acetate succinate) to achieve release enhancement, which shows limited effectiveness due to their leachability and susceptibility to larger pores or cracks [ 40 ]. The non-leachable TPN has the unique advantage of creating nano-scaled pores in response to high pH for an extended time, which is especially important for maintaining the structural integrity of the dosage form for prolonged or extended release [ 41 ].…”

Investigating in-vitro functionality and in-vivo taste assessment of eco-friendly Tadalafil Pastilles

“…Ltd., India. Kollicoat IR (75 % polyvinyl alcohol units and 25 % polyethylene glycol) [ 49 ], Ludiflash (84.0–92.0 % D-Mannitol, 4.0–6.0 % Kollidon® CL-SF, 3.5–6.0 % Polyvinyl acetate, 0.5–2.0 % water and 0.25–0.60 % Povidone) [ 50 ], and Soluplus (polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft co-polymer) [ 51 ] provided by BASF India Pvt. Ltd., India which are used to increase the release rate from the pastilles.…”

Design and Development of Multiparticulate Mini Tablets of Verapamil Hydrochloride for Pulsatile Drug Delivery

“…% drug released vs. Log time) to comprehend the kinetics and mechanism of drug release from minitablets. 9,10 Optimization studies…”